Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: J Clin Immunol. 2012 Oct 18;33(2):10.1007/s10875-012-9817-6. doi: 10.1007/s10875-012-9817-6

Fig. 6. Sarcoidosis Th-17 cells demonstrate reduced IFNγ expression.

Fig. 6

a Representative gating strategy used for identification of the IFN-γ producing CD4+IL-17A+cells. b Percent of Th-17 cells producing IFN-γ following polyclonal activation of PBMC from healthy controls (triangles, n=9) and sarcoidosis patients (squares, n=24). c Median fluorescent intensity (MFI) of IFN-γ expression on CD4+IL-17A+cells following polyclonal activation of PBMC of healthy controls (triangles, n=9) and sarcoidosis patients (circles, n=24). P values are indicated